GOFEN & GLOSSBERG LLC /IL/ - GW PHARMACEUTICALS PLC ownership

GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 277 filers reported holding GW PHARMACEUTICALS PLC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.

Quarter-by-quarter ownership
GOFEN & GLOSSBERG LLC /IL/ ownership history of GW PHARMACEUTICALS PLC
ValueSharesWeighting
Q1 2021$365,000
+76.3%
1,6850.0%0.01%
+28.6%
Q2 2020$207,000
-37.5%
1,685
-41.4%
0.01%
-36.4%
Q3 2019$331,000
-33.3%
2,8750.0%0.01%
-35.3%
Q2 2019$496,000
+2.3%
2,8750.0%0.02%0.0%
Q1 2019$485,000
+73.2%
2,8750.0%0.02%
+54.5%
Q4 2018$280,000
-21.3%
2,875
+39.6%
0.01%
-8.3%
Q3 2018$356,0002,0600.01%
Other shareholders
GW PHARMACEUTICALS PLC shareholders Q3 2020
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 390,000$45,010,0007.31%
Copernicus Capital Management, LLC 2,788$322,0005.02%
Integral Health Asset Management, LLC 72,500$8,367,0002.49%
Parkman Healthcare Partners LLC 81,573$9,414,0002.41%
AdvisorShares Investments LLC 66,317$7,654,0001.78%
Tri Locum Partners LP 40,159$4,635,0001.68%
ETF MANAGERS GROUP, LLC 621,361$71,711,0001.57%
Redmile Group, LLC 815,681$94,138,0001.14%
Redwood Investments, LLC 108,999$12,580,0001.07%
ROOSEVELT INVESTMENT GROUP LLC 127,885$14,759,0001.05%
View complete list of GW PHARMACEUTICALS PLC shareholders